Inotrope and vasopressor use in cardiogenic shock: what, when and why ?

CS continues to carry a high risk of morbidity and mortality. The mainstay of pharmacotherapy lies with vasopressors and inotropes, although dedicated and comparative evidence in the CS population remains sparse. Common inotrope agents include dobutamine, milrinone and levosimendan, each with their own hemodynamic and clinical benefits and risks.

View fullsize

Reference

Thanks to the authors.